1,4-dimethylcyclohex-3-en-1-ol | 70837-28-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1,4-dimethylcyclohex-3-en-1-ol
• 英文别名: 1,4-Dimethyl-3-cyclohexenol；1,4-Dimethyl-3-cyclohexen-1-ol
• CAS: 70837-28-4
• 化学式: C₈H₁₄O
• 分子量: 126.199
• InChiKey: RKJPTJHORFPYMH-UHFFFAOYSA-N

物化性质

• 沸点：
  38-40 °C(Press: 0.2 Torr)
• 密度：
  0.947±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1,4-dimethylcyclohex-3-en-1-ol 在 Crabtree catalyst 、 氢气 作用下， 以 二氯甲烷 为溶剂， 以15%的产率得到trans-1,4-dimethylcyclohexanol
  参考文献：
  名称：

  Stereocontrol in homogeneous catalytic hydrogenation via hydroxyl group coordination

  摘要：

  DOI：

  10.1021/ja00342a080
• 作为产物：
  描述：

  4-甲基-3-环己烯-1-酮 、 甲基锂 以97%的产率得到
  参考文献：
  名称：

  SNOWDEN, ROGER L.;BRAUCHLI, ROBERT;SONNAY, PHILIPPE, HELV. CHIM. ACTA, 72,(1989) N, C. 570-593

  摘要：

  DOI：

文献信息

• ?-Cleavage of Potassium Bicyclo[2.2.2]oct-5-en-2-olates. Stereoselective synthesis of (�)-trichodiene
  作者：Roger L. Snowden、Robert Brauchli、Philippe Sonnay

  DOI：10.1002/hlca.19890720318

  日期：1989.5.3

  3-(cyclohex-3-enyl)-2-alkanones (III or IV), via β-cleavage of their potassium alkoxides in HMPA, has been investigated (cf. Table 1). As an illustration of this synthetic methodology, a stereoselective synthesis of (±)-trichodiene ((±)-1) is described which involves the β-cleavage of the tricyclic potassium alkoxides 46a and 47a to cyclopentanone 4 (cf. Scheme 7).

  的变换12双环[2.2.2]辛-5-烯-2-醇（V或VI）到3-（环己-3-烯基）-2-烷酮（III或IV），经由的β裂解其已经研究了HMPA中的醇钾盐（参见表1）。作为该合成方法的说明，描述了（±）-三茂二烯（（±）-1）的立体选择性合成，该合成涉及将三环烷氧基钾46a和47a裂解为环戊酮4（参见方案7）。
• PYRAZOLOPYRIDINE COMPOUND AS RET INHIBITOR AND APPLICATION THEREOF
  申请人：Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory

  公开号：EP3950685A1

  公开（公告）日：2022-02-09

  Disclosed is a series of pyrazolopyridine compounds, and application thereof in the preparation of RET kinase inhibitors for treatment. Specifically disclosed is the compound represented by formula (I), or a pharmaceutically acceptable salt thereof.

  本发明公开了一系列吡唑并吡啶化合物及其在制备治疗用 RET 激酶抑制剂中的应用。具体公开了式 (I) 所代表的化合物或其药学上可接受的盐。
• [EN] PYRAZOLOPYRIDINE COMPOUND AS RET INHIBITOR AND APPLICATION THEREOF<br/>[FR] COMPOSÉ DE PYRAZOLOPYRIDINE UTILISÉ COMME INHIBITEUR DE RET ET SON APPLICATION<br/>[ZH] 作为RET抑制剂的吡唑并吡啶类化合物及其应用
  申请人：MEDSHINE DISCOVERY INC

  公开号：WO2020200316A1

  公开（公告）日：2020-10-08

  本发明公开了一系列吡唑并吡啶类化合物，及其在制备治疗作为RET激酶抑制剂中的应用。具体公开了式（I）所示化合物或其药学上可接受的盐。
• Reaction of azoalkanes with isolable cation radical salts
  作者：Paul S. Engel、Donald M. Robertson、John N. Scholz、Henry J. Shine

  DOI：10.1021/jo00049a025

  日期：1992.11

  Three tertiary azoalkanes related in the sense acyclic, cyclic, and bicyclic are shown to evolve nitrogen upon oxidation with stable cation radical salts. Thus azo-tert-octane (ATO), 3,3,6,6-tetramethyl-1,2-diazacyclohexene (TMDAC), and 1,4-dimethyl-2,3-diazabicyclo[2.2.2]oct-2-ene (Me2DBO) react rapidly with thianthrenium perchlorate (Th.+ClO4-), tris(p-bromophenyl)aminium hexachloroantimonate (TBPA.+SbCl6-), and TBPA.+SbF6-. The ether and olefin products, which are formed in high yield in CH2Cl2/MeOH solvent, are not those expected from the usual free-radical decomposition of azoalkanes but instead implicate carbocations. Although the reaction stoichiometry clearly requires 2 equiv of cation radical salt to one of azoalkane, the mechanism is not yet clearly defined. A complication in these studies is found in the ability of certain cation radical salts to oxidize more azoalkane than expected based on the 2:1 stoichiometry.
• Brady, William T.; Norton, Scott J.; Ko, Jinren, Synthesis, 1985, # 6/7, p. 704 - 705
  作者：Brady, William T.、Norton, Scott J.、Ko, Jinren

  DOI：——

  日期：——